New Onset of Eosinophilic Granulomatosis with Polyangiitis Following mRNA-Based COVID-19 Vaccine

Anti-SARS-CoV-2 vaccines are safe and effective, also in individuals with allergic and immune-mediated diseases (IMDs). There are reports suggesting that vaccines may be able to trigger de-novo or exacerbate pre-existing IMDs in predisposed individuals. Eosinophilic granulomatosis with polyangiitis...

Descripción completa

Detalles Bibliográficos
Autores principales: Nappi, Emanuele, De Santis, Maria, Paoletti, Giovanni, Pelaia, Corrado, Terenghi, Fabrizia, Pini, Daniela, Ciccarelli, Michele, Selmi, Carlo Francesco, Puggioni, Francesca, Canonica, Giorgio Walter, Heffler, Enrico
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144767/
https://www.ncbi.nlm.nih.gov/pubmed/35632472
http://dx.doi.org/10.3390/vaccines10050716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9144767/
https://www.ncbi.nlm.nih.gov/pubmed/35632472
http://dx.doi.org/10.3390/vaccines10050716

Ejemplares similares